Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Non-cash Items: 2018-2021

Historic Non-cash Items for Autolus Therapeutics (AUTL) over the last 1 years, with Dec 2021 value amounting to $10,477.4 billion.

  • Autolus Therapeutics' Non-cash Items was N/A to $10,477.4 billion in Q4 2021 from the same period last year, while for Dec 2021 it was $10,477.4 billion, marking a year-over-year change of. This contributed to the annual value of $10,694.0 billion for FY2021, which is N/A change from last year.
  • According to the latest figures from Q4 2021, Autolus Therapeutics' Non-cash Items is $10,477.4 billion, which was up 65.17% from $6,343.3 billion recorded in Q3 2021.
  • Over the past 5 years, Autolus Therapeutics' Non-cash Items peaked at $10,477.4 billion during Q4 2021, and registered a low of $11,873 during Q4 2019.
  • For the 3-year period, Autolus Therapeutics' Non-cash Items averaged around $5,735.1 billion, with its median value being $6,137.2 billion (2020).
  • Per our database at Business Quant, Autolus Therapeutics' Non-cash Items crashed by 76.93% in 2019 and then increased by 10.32% in 2021.
  • Autolus Therapeutics' Non-cash Items (Quarterly) stood at $51,464 in 2018, then crashed by 76.93% to $11,873 in 2019, then reached $5,749.8 billion in 2020, then increased by 10.32% to $10,477.4 billion in 2021.
  • Its last three reported values are $10,477.4 billion in Q4 2021, $6,343.3 billion for Q3 2021, and $6,499.4 billion during Q2 2021.